@article{b0bf2c8f30e440f2ae36596fde5482f4,
title = "Clinical Challenges in the Management of Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Literature Review",
keywords = "Aromatase inhibitors, Cyclin-dependent kinase 4/6 inhibitors, Endocrine therapy, Fulvestrant, Hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer, Mammalian target of rapamycin inhibitors, Phosphoinositide 3-kinase pathway inhibitors, Selective estrogen receptor degrader",
author = "Gayathri Nagaraj and Ma, \{Cynthia X.\}",
note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",
year = "2021",
month = jan,
doi = "10.1007/s12325-020-01552-2",
language = "English",
volume = "38",
pages = "109--136",
journal = "Advances in Therapy",
issn = "0741-238X",
number = "1",
}